Europe Antiviral Drugs Market by Target DNA Polymerase, NS3 Protease, Reverse Transcriptase, and Others
The Europe Antiviral Drugs Market is expected to reach USD 10.41 billion by 2021 from USD 8.17 billion in 2016, growing at a CAGR of 4.98% during the forecast period, 2016-2021.
(EMAILWIRE.COM, September 05, 2017 ) From the past few years resistance is observed among viruses against different antiviral drugs with increasing diversity of viruses. This challenge leads to the evolution of broad spectrum antiviral drugs Market that specifically attack viruses at specified targets such as DNA Polymerase, NS3 Protease, & Reverse Transcriptase. These drugs are used to prevent or cure different viral infections such as HIV/AIDS, Hepatitis, influenza, and other viral infections. Europe is among the leading market for the product.
View Full Report @ http://www.marketdataforecast.com/market-reports/europe-antiviral-drugs-market-1589/
The growth of antiviral drugs in European market is majorly driven by factors such as increased public awareness, well-established supply chain, and increase in viral infection incidences. Additionally, dearth of broad spectrum antiviral drugs in the market provides huge opportunity for pharmaceutical companies to expand business in the region. The key restraints of the market are high cost involved in drug development, lack of incentivization, and side-effects of products such as nausea, diarrhea, and behavioral changes.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/europe-antiviral-drugs-market-1589/request-sample
The European Antiviral Drugs is segmented on the basis of Application, Target, and End-Users. Based on Application, the market is classified into HIV/AIDS, Hepatitis, Herpes, Influenza, and Others. On the basis of Target, the market is classified into DNA polymerase, NS3 Protease, Reverse transcriptase, and Others. On the basis of End Users, the market is classified into Hospitals, Research Institutes, and Laboratory Centers. The European market is geographically segmented into United Kingdom, Spain, Germany, Italy, and France.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/europe-antiviral-drugs-market-1589/inquire
The major companies dominating the Antiviral Drugs market are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc (USA), GlaxoSmithKline plc (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
View Full Report @ http://www.marketdataforecast.com/market-reports/europe-antiviral-drugs-market-1589/
The growth of antiviral drugs in European market is majorly driven by factors such as increased public awareness, well-established supply chain, and increase in viral infection incidences. Additionally, dearth of broad spectrum antiviral drugs in the market provides huge opportunity for pharmaceutical companies to expand business in the region. The key restraints of the market are high cost involved in drug development, lack of incentivization, and side-effects of products such as nausea, diarrhea, and behavioral changes.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/europe-antiviral-drugs-market-1589/request-sample
The European Antiviral Drugs is segmented on the basis of Application, Target, and End-Users. Based on Application, the market is classified into HIV/AIDS, Hepatitis, Herpes, Influenza, and Others. On the basis of Target, the market is classified into DNA polymerase, NS3 Protease, Reverse transcriptase, and Others. On the basis of End Users, the market is classified into Hospitals, Research Institutes, and Laboratory Centers. The European market is geographically segmented into United Kingdom, Spain, Germany, Italy, and France.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/europe-antiviral-drugs-market-1589/inquire
The major companies dominating the Antiviral Drugs market are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc (USA), GlaxoSmithKline plc (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results